Corbus Pharmaceuticals : Announces Topline Results from determine Phase 3 Study of Lenabasum for Treatment of Dermatomyositis (Form 8-K)
MarketScreener,
Corbus Pharmaceuticals Announces Topline Results from d eter m ine Phase 3 Study of Lenabasum for Treatment of Dermatomyositis ●…